News

ascopubs.org8y
Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report | Journal of Clinical Oncology - ASCO Publications
Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients PURPOSE: To determine the response rate, time to ...
The New England Journal of Medicine18y
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders | NEJM - New England Journal of Medicine
We report the results of a 25-year, open-label, uncontrolled study of sodium phenylacetate and sodium benzoate therapy (Ammonul, Ucyclyd Pharma) in 299 patients with urea-cycle disorders in whom ...
ascopubs.org8y
Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report | Journal of Clinical Oncology - ASCO Publications
The schedule consisted of a 2-week continuous, intravenous infusion followed by a 2-week rest period (14 days on, 14 days off). A starting dose of 400 mg/kg total body weight per day of phenylacetate ...